These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1617334)

  • 1. Receptor-targeted immunotherapy.
    Janson RW; Arend WP
    Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
    Quagliata F; Schenkelaars EJ; Ferrone S
    Isr J Med Sci; 1993; 29(2-3):154-9. PubMed ID: 8468170
    [No Abstract]   [Full Text] [Related]  

  • 3. The emerging role of biologics in rheumatic disease.
    Strand V
    J Rheumatol Suppl; 1992 Apr; 33():40-5. PubMed ID: 1593600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New treatments of rheumatoid arthritis for future use].
    Cantagrel A; Mazières B
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor gene therapy for autoimmune diseases.
    Fujio K; Okamura T; Okamoto A; Yamamoto K
    Ann N Y Acad Sci; 2007 Sep; 1110():222-32. PubMed ID: 17911437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
    Prud'homme GJ
    J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of T cells in rheumatoid arthritis: new subsets and new targets.
    Toh ML; Miossec P
    Curr Opin Rheumatol; 2007 May; 19(3):284-8. PubMed ID: 17414957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
    VanderBorght A; Geusens P; Raus J; Stinissen P
    Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of rheumatic diseases based on understanding genetic predisposition to the development of these diseases.
    Fathman CG
    Rheum Dis Clin North Am; 1992 Nov; 18(4):915-26. PubMed ID: 1280848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble T cell receptors: novel immunotherapies.
    Molloy PE; Sewell AK; Jakobsen BK
    Curr Opin Pharmacol; 2005 Aug; 5(4):438-43. PubMed ID: 15939669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
    Wauben MH
    Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.